NCT05188924View on ClinicalTrials.gov

Efficacy and Safety of DKF-306 in Patients With Periodontal Diseases

PHASE4UnknownINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

May 22, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

December 31, 2022

Conditions
Periodontal Diseases
Interventions
DRUG

DKF-306

Active ingredients

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

RECRUITING

Youngsung, Seoul

Sponsors
All Listed Sponsors
lead

Dongkook Pharmaceutical Co., Ltd.

INDUSTRY